Cytokine adsorption devices for treating respiratory failure in people with COVID-19- Medtech innovation briefing (MIB217)

Supportive evidence comes from an observational study and a series of case reports including 56 patients with COVID‑19 and respiratory failure, which show cytokine adsorption devices reduce levels of cytokines in blood in people with COVID‑19 and may help improve lung function.


National Institute for Health and Care Excellence